Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Deleobuvir is out of the running in the mad dash to bring new hepatitis C virus (HCV) drugs to the market.
Faldaprevir, deleobuvir and PPI-668 showed high promise in curing genotype 1a of hepatitis C virus in early trial results.
Faldaprevir and deleobuvir, plus ribavirin, cured genotype 1 of hepatitis C virus (HCV) in 52 to 69 percent of study participants in a recent...
Faldaprevir and deleobuvir (BI 207127), plus ribavirin, cured 95 percent of the participants with genotype 1b of hepatitis C virus in a Phase...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.